Pages that link to "Q84156945"
Jump to navigation
Jump to search
The following pages link to Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b /CD14⁻/CD15 /CD33 myeloid-derived suppressor cells and CD8 T lymphocytes in patients with advanced-stage non-small cell lung cancer (Q84156945):
Displaying 50 items.
- Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth (Q21560837) (← links)
- Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences (Q27027064) (← links)
- Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy (Q28069360) (← links)
- Monitoring of the Immune Dysfunction in Cancer Patients (Q28072712) (← links)
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected (Q28084627) (← links)
- Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs (Q28086980) (← links)
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment (Q28388630) (← links)
- "Of mice and men": arginine metabolism in macrophages (Q28395476) (← links)
- Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma (Q30661652) (← links)
- Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: a study in a tuberculosis-endemic country (Q31052412) (← links)
- Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. (Q33564156) (← links)
- CD14( )S100A9( ) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer (Q34043804) (← links)
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages (Q34044797) (← links)
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients (Q34250873) (← links)
- Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment (Q34502899) (← links)
- A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients (Q34570094) (← links)
- Higher frequencies of GARP( )CTLA-4( )Foxp3( ) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality (Q34648541) (← links)
- Molecular pathways: myeloid complicity in cancer (Q34725969) (← links)
- Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy (Q34810257) (← links)
- Stromal-dependent tumor promotion by MIF family members (Q34944820) (← links)
- Functional characterization of human Cd33 And Cd11b myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines (Q35082018) (← links)
- Myeloid-derived suppressor cells: paradoxical roles in infection and immunity (Q35143001) (← links)
- Analysis of monocytic and granulocytic myeloid-derived suppressor cells subsets in patients with hepatitis C virus infection and their clinical significance (Q35178139) (← links)
- Myeloid derived suppressor cells are present at high frequency in neonates and suppress in vitro T cell responses (Q35271470) (← links)
- A novel subset of B7-H3 CD14 HLA-DR-/low myeloid-derived suppressor cells are associated with progression of human NSCLC. (Q35506243) (← links)
- Complexity and challenges in defining myeloid-derived suppressor cells (Q35509317) (← links)
- Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis (Q35567331) (← links)
- Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer. (Q35799185) (← links)
- Myeloid-derived suppressor cells participate in preventing graft rejection (Q35852813) (← links)
- Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells. (Q36021465) (← links)
- Impact of the Sensory Neurons on Melanoma Growth In Vivo (Q36029972) (← links)
- CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer (Q36118086) (← links)
- Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients (Q36286498) (← links)
- Lung cancer: Biology and treatment options (Q36328370) (← links)
- Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4 CD25 FoxP3 Tregs from CD4 CD25-FoxP3- T cells (Q36332711) (← links)
- Myeloid derived suppressor cells in human diseases (Q36338349) (← links)
- Mouse CD11b Gr-1 myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis (Q36339119) (← links)
- Trial watch: Prognostic and predictive value of the immune infiltrate in cancer (Q36456483) (← links)
- MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study (Q36508191) (← links)
- Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer. (Q36600997) (← links)
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients (Q36733391) (← links)
- Abnormal T regulatory cells (Tregs: FOXP3 , CTLA-4 ), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuv (Q36744405) (← links)
- Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans (Q36761567) (← links)
- Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? (Q36821572) (← links)
- Antiretroviral Therapy Normalizes Autoantibody Profile of HIV Patients by Decreasing CD33⁺CD11b⁺HLA-DR⁺ Cells: A Cross-Sectional Study (Q36822345) (← links)
- Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer (Q36896764) (← links)
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. (Q36971755) (← links)
- Blood CD33( )HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer (Q36981510) (← links)
- Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care (Q36995660) (← links)
- Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy (Q37100179) (← links)